Circulating microRNA in Chronic Obstructive Pulmonary Disease
Skeletal muscle dysfunction in COPD is associated with increased morbidity. Novel agents might reverse skeletal muscle dysfunction through different mechanisms since the biopsy picture in COPD patients is heterogenous. Thus there is a need for a biomarker of skeletal muscle dysfunction which could b...
Main Author: | Donaldson, Anna |
---|---|
Other Authors: | Polkey, Michael; Kemp, Paul; Man, William |
Published: |
Imperial College London
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.656774 |
Similar Items
-
MicroRNA expression in regulatory T cells in chronic obstructive pulmonary disease
by: Chatila, Wissam M.
Published: (2015) -
Pulmonary MicroRNA Changes Alter Angiogenesis in Chronic Obstructive Pulmonary Disease and Lung Cancer
by: Clara E. Green, et al.
Published: (2021-07-01) -
Diaphragm function in chronic obstructive pulmonary disease
by: Polkey, Michael Iain
Published: (1998) -
Preliminary studies: differences in microRNA expression in asthma and chronic obstructive pulmonary disease
by: Małgorzata Pietrusińska, et al.
Published: (2016-08-01) -
The Predictive Value of microRNA-134 and microRNA-1233 for the Early Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Pulmonary Embolism
by: Peng L, et al.
Published: (2020-10-01)